SRI22818 is a drug candidate for the treatment of ALS. SRI-22818 increases NF-κB expression and activation and SOD2 levels in vitro and has activity in vivo in the SOD1-G93A reference model of ALS.
MedKoo Cat#: 558955
Name: SRI22818
CAS#: 1429221-68-0
Chemical Formula: C16H12BrNO3
Exact Mass: 345.0001
Molecular Weight: 346.18
Elemental Analysis: C, 55.51; H, 3.49; Br, 23.08; N, 4.05; O, 13.86
The following data is based on the product molecular weight 346.18 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |